COCA Call - 2018-2019 Influenza Season and Recommendations for Clinicians

View this email as a webpage: https://content.govdelivery.com/accounts/USCDC/bulletins/228a59b

COCA Call Banner

2018-2019 Influenza Season and Recommendations for Clinicians

Overview

Influenza activity in the United States is increasing and is expected to continue at elevated levels for several more weeks. Influenza A(H1N1)pdm09 viruses have been most common this season; influenza A(H3N2) and influenza B viruses are also circulating. In the southeastern part of the country, influenza A(H3N2) viruses have been most commonly reported this season. Annual influenza vaccination is recommended for all people 6 months and older and is the best way to prevent influenza and its potentially serious complications. Available evidence consistently indicates that antiviral treatment initiated as early as possible can be a useful second line of defense to treat influenza illness when indicated and can reduce severe outcomes of influenza.

During this COCA Call, clinicians will learn about 2018 –2019 influenza activity and hear an overview of CDC’s recommendations for health care providers regarding influenza vaccination and the use of influenza antiviral medications for the 2018-2019 influenza season, including a new antiviral medication approved by the FDA in October 2018.

health professional administering flu shot to patient

Date: Tuesday, January 29, 2019

Time: 2:00-3:00 PM ET

A few minutes before the webinar begins, please click the link below to join the webinar:

https://zoom.us/j/862187873

Or iPhone one-tap:

US: +16468769923,,862187873#  or +16699006833,,862187873#

Or Telephone:

US: +1 646 876 9923  or +1 669 900 6833

Webinar ID: 862 187 873

International numbers available here: https://zoom.us/u/afuFnVK9Q

The recordings (audio, slides, and transcript) for this call will be posted on the webpage a week after the COCA Call.

Free Continuing Education (CE) is available for most COCA Calls. Please see below for instructions on how to receive CE.